Anzeige
Mehr »
Montag, 24.08.2026 - Börsentäglich über 12.000 News
Geheime Kupferaktie: Kupfer auf Rekordhoch - steht dieser geheime Junior-Explorer jetzt vor einer Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4215G | ISIN: US0956336087 | Ticker-Symbol:
NASDAQ
21.08.26 | 21:45
0,912 US-Dollar
+0,12 % +0,001
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BLUEJAY DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
BLUEJAY DIAGNOSTICS INC 5-Tage-Chart

Aktuelle News zur BLUEJAY DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.08.Bluejay Diagnostics reports Q2 results1
13.08.Bluejay Diagnostics, Inc. - 8-K, Current Report-
13.08.Bluejay Diagnostics completes enrollment in sepsis test study1
BLUEJAY DIAGNOSTICS Aktie jetzt für 0€ handeln
13.08.Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization348SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate...
► Artikel lesen
12.08.Bluejay Diagnostics, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
22.07.Bluejay Diagnostics, Inc. - 8-K, Current Report1
21.07.Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study255ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today...
► Artikel lesen
09.06.Bluejay Diagnostics, Inc. - 8-K, Current Report1
06.06.Bluejay Diagnostics closes $8.5 million private placement1
06.06.Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules1
03.06.What's Going On With Bluejay Diagnostics Shares On Wednesday?3
02.06.Bluejay Diagnostics raises $8.5M in private placement2
02.06.Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules4
02.06.Why Is Bluejay Diagnostics Stock Soaring Tuesday?7
02.06.Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings718WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening...
► Artikel lesen
02.06.Bluejay Diagnostics partners with Argonaut for US manufacturing4
02.06.Bluejay Diagnostics, Inc.: Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership236ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company") (NASDAQ: BJDX), a medical diagnostics company focused on near-patient testing...
► Artikel lesen
02.06.Bluejay Diagnostics, Inc. - 8-K, Current Report2
07.05.Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides First Quarter 2026 Corporate Update210ACTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes in critical care settings...
► Artikel lesen
07.05.Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report-
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1